-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Zebra Technologies (ZBRA) Undervalued Following Its University Health Rollout?

Simply Wall St·09/08/2026 20:34:15
Listen to the news

Zebra Technologies (ZBRA) just highlighted a fresh healthcare win as University Health rolled out its mobile computers and printers across more than 90% of frontline inpatient staff.

For context, Zebra Technologies has seen strong momentum over the past quarter, with a 90 day share price return of 67.3% and a year to date share price gain of 46.1%. However, the 30 day share price return is down 3.7% and the 5 year total shareholder return is also lower.

Scan beyond Zebra Technologies and see how other automation and healthcare-focused players line up inside our curated list of 36 robotics and automation stocks.

After a 67.3% run over 90 days, yet still trading about 13% below average analyst targets and at a larger intrinsic discount, is the market sensibly cautious on Zebra Technologies, or is it mispricing the rebound story?

Most Popular Narrative: 9.1% Undervalued

Against a last close of $362.74, the most followed narrative for Zebra Technologies points to a fair value of $399.00, leaving a modest valuation gap that hinges on how confident you are in its margin and earnings path.

Continued pivot toward higher-margin, recurring revenue streams (e.g., SaaS, software, and services) and ongoing operational efficiencies (including tariff mitigation, global supply chain optimization, and portfolio rationalization) are expected to improve EBITDA margins and earnings stability over time. Zebra's deeply embedded, mission-critical solutions coupled with a growing installed base and high customer retention, especially as customers undertake multi-year digital upgrade and device refresh cycles, underpin predictable cash flows and sustained growth in both revenue and free cash flow conversion.

Read the complete narrative.

Want to see what really sits behind that fair value for Zebra Technologies? The narrative leans on a tight mix of projected revenue gains, margin rebuild and a future earnings multiple that differs from where the stock trades today. If you are curious which specific assumptions carry the most weight in that $399.00 figure, the full breakdown is where those numbers start to speak.

Result: Fair Value of $399.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, Zebra Technologies carries two pressure points that could flip this narrative: weaker progress in shifting from hardware to software, and tougher tariff or trade conditions hitting margins.

Find out about the key risks to this Zebra Technologies narrative.

Next Steps

Mixed signals in the Zebra Technologies story today. If you want to move fast and build your own judgement, start by weighing the upside against the concerns through the 2 key rewards and 2 important warning signs.

Looking for more ideas beyond Zebra Technologies?

There is no reason to stop with Zebra Technologies when plenty of other potential opportunities are just a few smart filters away on the Simply Wall Street Screener.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.